BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation

Summary

The goal of this open label randomised clinical trial is to compare Bivalirudin versus Heparin for anticoagulation in patients requiring extracorporeal membrane oxygenation support. The main question it aims to answer are include the ability to maintain anticoagulation within defined therapeutic range, bleeding and thrombotic complications and a comparison of the total cost of anticoagulation care. Participants will be randomised to either anticoagulation with Bivalirudin or anticoagulation with Unfractionated Heparin.

Timeline

Start

2024-05-01

Primary completion

2026-06-01

Completion

2026-09-01

Drugs

Indications

No indication recorded.